| Tri-county Community Action Agency | |
|
1126 Hartford Ave Johnston RI 02919-7130 | |
| (401) 351-2750 | |
| (401) 351-6613 |
| Full Name | Tri-county Community Action Agency |
|---|---|
| Speciality | Clinic/Center |
| Location | 1126 Hartford Ave, Johnston, Rhode Island |
| Authorized Official Name and Position | Joseph R Desantis (CHIEF EXECUTIVE OFFICER) |
| Authorized Official Contact | 4015191967 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tri-county Community Action Agency 1126 Hartford Ave Johnston RI 02919-7130 Ph: (401) 351-2750 | Tri-county Community Action Agency 1126 Hartford Ave Johnston RI 02919-7130 Ph: (401) 351-2750 |
| NPI Number | 1396780086 |
|---|---|
| Provider Enumeration Date | 06/18/2006 |
| Last Update Date | 12/12/2023 |
| Certification Date | 12/12/2023 |
| Medicare PECOS PAC ID | 0648171181 |
|---|---|
| Medicare Enrollment ID | O20040116000778 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396780086 | NPI | - | NPPES |
| TT02485 | Medicaid | RI |
| Provider Name | Diane M Kuttner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356395578 PECOS PAC ID: 1052413788 Enrollment ID: I20070226000719 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Karen M Lachapelle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871892042 PECOS PAC ID: 4789857244 Enrollment ID: I20111027000607 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Suzanne E Lowe |
|---|---|
| Provider Type | Practitioner - Certified Nurse Midwife (cnm) |
| Provider Identifiers | NPI Number: 1457307258 PECOS PAC ID: 3870743412 Enrollment ID: I20121017000464 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Richard Chartier |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1265578058 PECOS PAC ID: 2062440951 Enrollment ID: I20130919000546 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Wilfredo Giordano-perez |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1902148141 PECOS PAC ID: 3072748722 Enrollment ID: I20170915000973 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Rebecca M Friedman |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1639331424 PECOS PAC ID: 6800018995 Enrollment ID: I20171013001531 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Patricia L Giarrusso |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538492525 PECOS PAC ID: 1759427131 Enrollment ID: I20171228000602 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Marcie E Diorio |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1306382932 PECOS PAC ID: 5092069385 Enrollment ID: I20181127001107 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Casey Ellyn Sardo |
|---|---|
| Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
| Provider Identifiers | NPI Number: 1902318090 PECOS PAC ID: 0244574093 Enrollment ID: I20181204003962 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Alice Mui |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275032476 PECOS PAC ID: 8729312376 Enrollment ID: I20190702000266 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Rose Michelle Tilus |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1487273363 PECOS PAC ID: 8628498532 Enrollment ID: I20201014003674 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Joseph Albertario |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1326424466 PECOS PAC ID: 9032539960 Enrollment ID: I20201015000445 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Caroline S. Murray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366051849 PECOS PAC ID: 5698185320 Enrollment ID: I20201106002177 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Mellissa Lacroix-dwyer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1790396935 PECOS PAC ID: 7214348390 Enrollment ID: I20201120001078 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Edmundo Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1710384896 PECOS PAC ID: 4082993357 Enrollment ID: I20210125001335 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Stephen Joseph Thomas |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1437171790 PECOS PAC ID: 3072928217 Enrollment ID: I20210219001616 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Raj Pande |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1215044458 PECOS PAC ID: 2860798261 Enrollment ID: I20210301000948 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Habiba H. Kure |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1275263329 PECOS PAC ID: 0941679542 Enrollment ID: I20221202001580 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Nikia A Dasilva-lopes |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770205015 PECOS PAC ID: 4587024112 Enrollment ID: I20230714000831 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Hafida Zerouali |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1184241895 PECOS PAC ID: 9638539265 Enrollment ID: I20230714000974 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Barbara Ann Chadwick |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477039543 PECOS PAC ID: 3577923556 Enrollment ID: I20230721003185 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Jennifer Anne Caffrey |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1285113571 PECOS PAC ID: 5698199552 Enrollment ID: I20230724000668 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Cindia Arsenault |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1265105597 PECOS PAC ID: 6002277829 Enrollment ID: I20230726002541 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Tiffany Brown |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1922676055 PECOS PAC ID: 3274996046 Enrollment ID: I20230825002401 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Kelli Anne Welby |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235648163 PECOS PAC ID: 2567722093 Enrollment ID: I20230918002993 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Amanda Masi |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1922675164 PECOS PAC ID: 5395199459 Enrollment ID: I20230925000870 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Kasandra Henriques |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1265135099 PECOS PAC ID: 0941654891 Enrollment ID: I20230926001847 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
| Provider Name | Jermaine Porter |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821778705 PECOS PAC ID: 3476907353 Enrollment ID: I20230926002832 |
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
News Archive
Knocking out one or both crucial regulatory genes caused cleft lip, skin barrier defects, and a host of other developmental problems in mice, according to new research from the Perelman School of Medicine at the University of Pennsylvania, hinting that abnormalities in these molecular pathways could underlie many birth defects that are presently not well understood. The two closely related regulatory genes are active in the normal development of mammals and govern how RNAs produced from the genes are joined to make final versions of the encoded protein, a process called alternative splicing.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the "Soutschek and Manoharan" patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.
Reaching underserved populations who are newly qualified for coverage remains a major concern and challenge to advocacy groups like Families USA. For insurers and government officials, the target is healthy people who will help balance new risk pools.
The UK government has announced that boys in England aged 12 to 13 years are to be vaccinated against human papillomavirus, or HPV. This injection would protect them against HPV infection. HPV infection has been linked to cervical cancer in women and oral, penile, throat and anal cancer among men.
› Verified 7 days ago
The Journey To Hope, Health & Healing, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 985 Plainfield Street, Johnston, RI 02919 Phone: 401-946-0650 Fax: 401-406-3771 | |
Tri-town Substance Abuse Program Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1126 Hartford Ave, Johnston, RI 02919 Phone: 401-351-2750 Fax: 401-351-6613 | |
Gateway Healthcare, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1443 Hartford Ave, Johnston, RI 02919 Phone: 401-553-1033 Fax: 401-861-8696 | |
Albert J. Marano, Md, Inc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1526 Atwood Ave, Suite 200, Johnston, RI 02919 Phone: 401-272-7660 Fax: 401-421-2730 | |
Delta Consultants West, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1395 Atwood Ave, Suite 213, Johnston, RI 02919 Phone: 401-944-9888 Fax: 401-944-5888 | |
Ocean State Counseling And Wellness Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1395 Atwood Ave, Suite 206, Johnston, RI 02919 Phone: 401-241-3344 Fax: 888-458-2467 | |
Bhg Lvii, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 985 Plainfield St, Johnston, RI 02919 Phone: 401-946-0650 |